Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201205056 Principal Investigator: Linette, Gerald
Title: A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients with a High Risk of Recurrence
Phase: III Disease Site: Melanoma, Skin
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this study is to determine how safe and how well POL-103A works in preventing the relapse of melanoma after patients have undergone surgery.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)